140 related articles for article (PubMed ID: 388650)
1. Reduction of myocardial ischemic injury and left ventricular dysfunction by vasodilator therapy.
Carraway RD
South Med J; 1979 Nov; 72(11):1436-44. PubMed ID: 388650
[No Abstract] [Full Text] [Related]
2. Pathophysiology of myocardial ischaemia and the prevention of necrosis.
Taylor RR
Clin Exp Pharmacol Physiol Suppl; 1982; 6():67-74. PubMed ID: 6126288
[No Abstract] [Full Text] [Related]
3. Vasodilator therapy of cardiac failure (second of two parts).
Cohn JN; Franciosa JA
N Engl J Med; 1977 Aug; 297(5):254-8. PubMed ID: 327319
[No Abstract] [Full Text] [Related]
4. Vasodilator therapy in acute left ventricular failure (LVF) after acute myocardial infarction (AMI).
Gandhi MJ; Hiremath MS; Viswanath M
Indian Heart J Teach Ser; 1980; (5):181-6. PubMed ID: 7461672
[No Abstract] [Full Text] [Related]
5. Pentaerythritol Tetranitrate Targeting Myocardial Reactive Oxygen Species Production Improves Left Ventricular Remodeling and Function in Rats With Ischemic Heart Failure.
Fraccarollo D; Galuppo P; Neuser J; Bauersachs J; Widder JD
Hypertension; 2015 Nov; 66(5):978-87. PubMed ID: 26351025
[TBL] [Abstract][Full Text] [Related]
6. Vasodilator therapy for heart failure. The influence of impedance on left ventricular performance.
Cohn JN
Circulation; 1973 Jul; 48(1):5-8. PubMed ID: 4781249
[No Abstract] [Full Text] [Related]
7. The role of vasodilator therapy in heart failure.
Chatterjee K; Parmley WW
Prog Cardiovasc Dis; 1977; 19(4):301-25. PubMed ID: 401541
[TBL] [Abstract][Full Text] [Related]
8. Effects of molsidomine on hemodynamics and blood gases in acute myocardial infarction with left heart failure.
Renard M; Jacobs P; Liebens I; Friart A; Bernard R
Am Heart J; 1985 Mar; 109(3 Pt 2):720-2. PubMed ID: 3919551
[TBL] [Abstract][Full Text] [Related]
9. Effects of amlodipine on myocardial infarction, infarct expansion, and ventricular geometry in the rat.
Hagar JM; Newman LG; Kloner RA
Am Heart J; 1992 Sep; 124(3):571-80. PubMed ID: 1387506
[TBL] [Abstract][Full Text] [Related]
10. [Limitations of long-term treatment with vasodilator agents in increasing maximum functional capacity in patients with left ventricular insufficiency].
Gronda E; Mafrici A; Ferrari D; Cataldo G; Salvadè P; Pirelli S; Mauri F; Faletra F; Carù B
G Ital Cardiol; 1981; 11(6):803-11. PubMed ID: 7319186
[No Abstract] [Full Text] [Related]
11. 5-Fluorouracil cardiotoxicity: left ventricular dysfunction and effect of coronary vasodilators.
Patel B; Kloner RA; Ensley J; Al-Sarraf M; Kish J; Wynne J
Am J Med Sci; 1987 Oct; 294(4):238-43. PubMed ID: 3661619
[TBL] [Abstract][Full Text] [Related]
12. Selection of vasodilator, inotropic or combined therapy for the management of heart failure.
Cohn JN; Franciosa JA
Am J Med; 1978 Jul; 65(1):181-8. PubMed ID: 685992
[TBL] [Abstract][Full Text] [Related]
13. Reduction of ischemic injury by nitroglycerin during acute myocardial infarction.
Epstein SE; Kent KM; Goldstein RE; Borer JS; Redwood DR
N Engl J Med; 1975 Jan; 292(1):29-35. PubMed ID: 803223
[No Abstract] [Full Text] [Related]
14. The use of vasodilator agents in the treatment of heart failure.
Lloyd EA
S Afr Med J; 1979 Nov; 56(20):787-95. PubMed ID: 159502
[TBL] [Abstract][Full Text] [Related]
15. Vasodilators have not been shown to be of value in all patients with chronic congestive heart failure due to left ventricular systolic dysfunction.
Kulick DL; Rahimtoola SH
Am J Cardiol; 1990 Aug; 66(4):435-8. PubMed ID: 2201177
[No Abstract] [Full Text] [Related]
16. The role of digitalis in acute myocardial infarction.
Liberman HA
Prim Care; 1981 Sep; 8(3):483-90. PubMed ID: 6914672
[TBL] [Abstract][Full Text] [Related]
17. [Area of the ischemic lesion in acute myocardial infarct: critical review of the use of vasodilator agents].
Permutti B; Costa PP; Fernandes P; Locatelli C
Boll Soc Ital Cardiol; 1980; 25(7):803-5. PubMed ID: 7272077
[No Abstract] [Full Text] [Related]
18. Pathophysiology of hypertension and ischemic heart disease.
Prys-Roberts C
Int Anesthesiol Clin; 1980; 18(4):1-23. PubMed ID: 6450170
[No Abstract] [Full Text] [Related]
19. Peripheral vasodilators in the treatment of cardiac failure.
Forrester JS; da Luz PL
Adv Cardiol; 1976; 17():123-32. PubMed ID: 818884
[No Abstract] [Full Text] [Related]
20. [Physiology of coronary circulation as the basis for the evaluation of coronary dilator agents].
Lochner W
Arzneimittelforschung; 1970 Mar; 20():424-32. PubMed ID: 4989252
[No Abstract] [Full Text] [Related]
[Next] [New Search]
